VAC_96_2025 - ASSOCIATED RESEARCHER

The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.

The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).

The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.

We are looking for an Associated Researcher to join the Cancer genetics Group led by Dr. Montse Sanchez - Cespedes at our institute.

RESEARCH DESCRIPTION

The complete genetic characterization of tumours is important to understand cancer development, promote the discovery of new drugs and improve the selection of patients that may benefit from a given cancer therapy. Our research uses the latest high-throughput sequencing technologies to create profiles and catalogues of the recurrently altered genes in cancer. We also have a keen interest in understanding the mechanisms by which the abnormal function of these genes contributes to cancer development.

MAIN RESPONSABILITIES

• Responsibility and management of the Genetics and Chromatin Modifications in Leukemia research line
• Projects application and management
• Support to internal and external projects.
• PhD co-supervision

WHAT WE NEED

• PhD in Life Sciences
• Postdoctoral experience of at least 8 years
• Experience in genetics of chromatin remodeling in cancer
• Experience in leading Research projects
• Experience in supervising students
• Experience in projects application, both public and private calls.
• Proficient in writing and speaking in English.
• Leadership and teamworking
• Communication skills
• Proactivity, initiative and solving problem’s ability
• Organized, self-motivated, and enthusiastic.
• High motivation biomedical research
• Capacity for analysis and supervision.

WHAT WE OFFER

• Full time contract.
• Temporary contract (contrato de interinidad hasta cobertura de plaza indefinida)
• Contract details will take into account the track record of the candidate.
• Incorporation in a multinational and highly collaborative team.
• An innovative and interdisciplinary research project.
• Mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.
• Flexible remuneration program (kindergarten and other measures).
• The stimulating environment of the Barcelona metropolitan area.

DEADLINE

Please submit your application by November 17th, 2025

WHO WE ARE?

What makes us different?

The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social res